Pulse Biosciences, Inc.
NASDAQ:PLSE
17.74 (USD) • At close April 17, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0.7 | 1.418 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 1.207 | 11.944 | 1.968 | 0.665 | 0.666 | 0.665 | 0.665 | 0.665 | 0 | 0 |
| Gross Profit
| 0 | -1.207 | -11.244 | -0.55 | -0.665 | -0.666 | -0.665 | -0.665 | -0.665 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | -16.063 | -0.388 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 32.336 | 27.797 | 20.839 | 28.64 | 26.444 | 24.961 | 17.253 | 9.646 | 5.988 | 2.578 | 0.045 |
| General & Administrative Expenses
| 23.921 | 15.777 | 13.955 | 19.073 | 22.856 | 22.327 | 20.045 | 15.503 | 2.933 | 1.224 | 0.074 |
| Selling & Marketing Expenses
| 0 | 0 | 12.019 | 14.751 | 7.256 | 5.857 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 23.921 | 15.777 | 25.974 | 33.824 | 22.856 | 22.327 | 20.045 | 15.503 | 2.933 | 1.224 | 0.074 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0.665 | 0.666 | -0.028 | 0.665 | 0.665 | 0.665 | 0 |
| Operating Expenses
| 56.257 | 43.574 | 46.813 | 62.464 | 49.965 | 47.954 | 37.963 | 25.814 | 9.586 | 4.468 | 0.514 |
| Operating Income
| -56.257 | -43.574 | -58.057 | -63.014 | -49.965 | -47.954 | -37.963 | -25.814 | -9.586 | -4.468 | -0.309 |
| Operating Income Ratio
| 0 | 0 | -82.939 | -44.439 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 2.672 | 1.364 | -0.448 | -0.646 | 0.114 | 0.983 | 0.418 | 0.247 | 0.068 | 0 | -0.396 |
| Income Before Tax
| -53.585 | -42.21 | -58.505 | -63.66 | -49.851 | -46.971 | -37.545 | -25.567 | -9.518 | -4.468 | -0.514 |
| Income Before Tax Ratio
| 0 | 0 | -83.579 | -44.894 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0.448 | -0.5 | -0.114 | -0.983 | -0.028 | -0.912 | -0.094 | -1.657 | 0.039 |
| Net Income
| -53.585 | -42.21 | -58.953 | -63.16 | -49.737 | -45.988 | -37.545 | -25.567 | -9.518 | -2.811 | -0.475 |
| Net Income Ratio
| 0 | 0 | -84.219 | -44.542 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.92 | -0.88 | -1.74 | -2.26 | -2.14 | -2.22 | -2.2 | -1.73 | -0.86 | -0.37 | -0.19 |
| EPS Diluted
| -0.92 | -0.88 | -1.74 | -2.26 | -2.14 | -2.22 | -2.2 | -1.73 | -0.86 | -0.37 | -0.19 |
| EBITDA
| -56.257 | -42.367 | -56.702 | -61.868 | -48.87 | -46.794 | -36.653 | -24.566 | -8.827 | -3.751 | -0.108 |
| EBITDA Ratio
| 0 | 0 | -81.003 | -43.63 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |